(19)
(11) EP 2 543 249 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 A1)

(48) Corrigendum issued on:
14.08.2013 Bulletin 2013/33

(43) Date of publication:
09.01.2013 Bulletin 2013/02

(21) Application number: 12187402.8

(22) Date of filing: 19.02.2008
(51) International Patent Classification (IPC): 
A01N 1/02(2006.01)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

(30) Priority: 17.02.2007 US 901844 P
20.02.2007 US 902587 P
27.08.2007 US 966511 P

(62) Application number of the earlier application in accordance with Art. 76 EPC:
08725769.7 / 2124539

(71) Applicants:
  • President and Fellows of Harvard College
    Cambridge, MA 02138 (US)
  • The United States Government as Represented by the Department of Veterans Affairs
    Washington, DC 20420 (US)

(72) Inventors:
  • Thatte, Hemant
    Medfield, MA 02052 (US)
  • Treanor, Patrick
    Dedham, MA 02026 (US)
  • Khuri, Shukri
    deceased (US)
  • Rousou, Laki
    New York, NY 10065 (US)

(74) Representative: Mintz Levin Cohn Ferris Glovsky and Popeo LLP 
Alder Castle 10 Noble Street
London EC2V 7JX
London EC2V 7JX (GB)

 
Remarks:
This application was filed on 05-10-2012 as a divisional application to the application mentioned under INID code 62.
 


(54) Compositions and method for tissue preservation


(57) Methods and compositions for resuscitating, storing, and preserving functional integrity of organs and tissues. Metabolic function is maintained by sustaining ATP levels, mitochondrial function, cardiomyocyte contractility, prevention of acidosis, inhibition of induction of apoptosis, maintaining ionontrophy and lusiotrophy by regulating calcium, sodium, potassium and chloride ions.